CS802086A2 - Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production - Google Patents

Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Info

Publication number: CS802086A2
Authority: CS; Czechoslovakia
Prior art keywords: opt; alkyl; substd; alkoxy; etherified
Prior art date: 1985-06-18

Application number

CS868020A

Other languages

English (en)

Other versions

CS268686B2 (en

Inventor

Leslie J Dr Browne

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-06-18

Filing date

1986-11-05

Publication date

1989-07-12

1985-06-18 Priority claimed from CS854449A external-priority patent/CS268672B2/cs

1986-11-05 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1986-11-05 Priority to CS868020A priority Critical patent/CS268686B2/cs

1989-07-12 Publication of CS802086A2 publication Critical patent/CS802086A2/cs

1990-04-11 Publication of CS268686B2 publication Critical patent/CS268686B2/cs

Links

JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 1
MHOZZUICEDXVGD-UHFFFAOYSA-N pyrrolo[2,3-d]imidazole Chemical class C1=NC2=CC=NC2=N1 MHOZZUICEDXVGD-UHFFFAOYSA-N 0.000 title 1
-1 alkanoyl alkanoyloxy Chemical group 0.000 abstract 10
125000000217 alkyl group Chemical group 0.000 abstract 9
125000003545 alkoxy group Chemical group 0.000 abstract 6
229910052736 halogen Inorganic materials 0.000 abstract 6
150000002367 halogens Chemical class 0.000 abstract 6
125000001589 carboacyl group Chemical group 0.000 abstract 5
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 5
125000004423 acyloxy group Chemical group 0.000 abstract 4
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 4
125000004414 alkyl thio group Chemical group 0.000 abstract 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 abstract 3
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 2
229910006069 SO3H Inorganic materials 0.000 abstract 2
125000005078 alkoxycarbonylalkyl group Chemical group 0.000 abstract 2
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
125000004181 carboxyalkyl group Chemical group 0.000 abstract 2
125000004663 dialkyl amino group Chemical group 0.000 abstract 2
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
125000003884 phenylalkyl group Chemical group 0.000 abstract 2
125000004660 phenylalkylthio group Chemical group 0.000 abstract 2
125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 2
102000014654 Aromatase Human genes 0.000 abstract 1
108010078554 Aromatase Proteins 0.000 abstract 1
229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
125000005042 acyloxymethyl group Chemical group 0.000 abstract 1
125000004849 alkoxymethyl group Chemical group 0.000 abstract 1
125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
125000005278 alkyl sulfonyloxy group Chemical group 0.000 abstract 1
125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
125000002619 bicyclic group Chemical group 0.000 abstract 1
125000005117 dialkylcarbamoyl group Chemical group 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 abstract 1
125000004970 halomethyl group Chemical group 0.000 abstract 1
CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CS868020A 1985-06-18 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production CS268686B2 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CS868020A CS268686B2 (en)	1985-06-18	1986-11-05	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CS854449A CS268672B2 (en)	1984-06-20	1985-06-18	Method of substituted imidazo-(1,5-a)pyridine derivatives production
CS868020A CS268686B2 (en)	1985-06-18	1986-11-05	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Publications (2)

Publication Number	Publication Date
CS802086A2 true CS802086A2 (en)	1989-07-12
CS268686B2 CS268686B2 (en)	1990-04-11

Family

ID=5387250

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CS868020A CS268686B2 (en)	1985-06-18	1986-11-05	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
CS868022A CS268688B2 (en)	1985-06-18	1986-11-05	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
CS868022A CS268688B2 (en)	1985-06-18	1986-11-05	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Country Status (1)

Country	Link
CS (2)	CS268686B2 (cs)

1986
- 1986-11-05 CS CS868020A patent/CS268686B2/cs not_active IP Right Cessation
- 1986-11-05 CS CS868022A patent/CS268688B2/cs not_active IP Right Cessation

Also Published As

Publication number	Publication date
CS802286A2 (en)	1989-07-12
CS268688B2 (en)	1990-04-11
CS268686B2 (en)	1990-04-11

Similar Documents

Publication	Publication Date	Title
SE8802815L (sv)	1989-02-05	Epipodofyllotoxin-glukosid-4'-fosfat-derivat
ATE182792T1 (de)	1999-08-15	Wundheilung
EP0213776A3 (en)	1989-05-03	Use of a cartilage-inducing factor (cif) for the manufacture of a medicament for treating inflammation
PT646012E (pt)	2003-03-31	Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
TR200201052T2 (tr)	2003-01-21	Yeni hücre farklılaştırıcı ajanlar sınıfı ve hıstone deacetylase inhibitörleri, ve burada kullanım yöntemleri
Cassin et al.	1986	The effects of bumetanide and furosemide on lung liquid secretion in fetal sheep
Schneider et al.	1995	Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
CS802086A2 (en)	1989-07-12	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
NZ333063A (en)	2000-12-22	Dibenzofuran sulfonamide derivatives as matrix metalloproteinase inhibitors
CS801886A2 (en)	1989-07-12	Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
DE69807710D1 (de)	2002-10-10	Verwendung von Latenz Assoziierten Peptiden in der Herstellung eines Medikaments zur Verbesserung der Wundheilung.
NO880731L (no)	1988-08-22	Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.
DE60017147D1 (de)	2005-02-03	Verwendung von gabab-rezeptor agonisten und deren pharmazeutisch akzeptierbaren derivate bei der therapie zur erhaltung von nikotinabstinenz bei nikotinabhängigen patienten
Huang et al.	1998	Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbutyrate.
NZ322202A (en)	2000-05-26	Aminocycloalkylpyrrolidine derivatives and salts thereof with antibacterial activity
EA200100214A1 (ru)	2001-08-27	Применение производных камптотецина с пониженной гастроинтестинальной токсичностью
NO950360D0 (no)	1995-01-31	Nytt legemiddel som inneholder 3-fenylsulfonyl-3,7-diazabisyklo[3,3,1Ånonan-forbindelser
DK0533210T3 (da)	1997-11-03	Protein C-holdige farmaceutiske præparater som midler mod inflammation.
Tomono et al.	1995	Synergistic potentiating effects of choline phosphate and ethanolamine on insulin-induced DNA synthesis in NIH 3T3 fibroblasts
AU3818989A (en)	1990-01-25	The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages
Klos et al.	1985	Prilocaine-induced methemoglobinemia in a child with Shwachman syndrome
DE3889497D1 (de)	1994-06-16	3,4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-e]-1,2-thiazine-4-carboxamid-1,1-dioxide.
FR2307536A1 (fr)	1976-11-12	Derives d'acide 5-sulfamoyl-anthranilique a substituants basiques et leur procede de preparation
EP0327052A3 (en)	1990-12-12	Use of quinoline derivatives for making a medicament effective in the prevention and treatment of ulcers
EP0209089A3 (en)	1990-01-31	Use of quinazolines in the preparation of a medicament for treating and preventing ischemic cardiac disease or arrhythmia

Legal Events

Date	Code	Title	Description
2000-08-16	MK4A	Patent expired	Effective date: 20000618